TEM-STEM study of europium doped gadolinium oxide nanoparticles synthesized by spray pyrolysis

Proocedings of: Fourth Conference on the Characterization and Control of Interfaces for High Quality Advanced Materials. Kurashiki, Japan, 02-05 September 2012.Scanning-Transmission and Transmission Electron Microscopy techniques (STEM and TEM) have been applied to the characterization of nanostructured gadolinium oxides doped with europium synthesized by spray pyrolysis. The High Angle Annular Dark Field (HAADF) &- Scanning Transmission Electron Micros-copy (STEM) tools have been used to perform a tomographic study to identify morphological character-istics of nanostructured particles, and to differentiate them according to the heat treatments to which these have been subjected. With these techniques it has been possible to confirm the hollowness and por-ous nature of samples subjected to low temperature annealing (900 ºC). Moreover, the beginning of the densification and sintering processes in samples subjected to thermal treatment at higher temperature (1100 ºC) have been evaluated. Chemical analysis by electron energy loss spectroscopy (EELS) and X ray energy dispersive spectroscopy (EDS) carried out in STEM mode have allowed to confirm the high uni-formity and the expected chemical composition. The high resolution tools either allowed to confirm the presence of a cubic (Ia3 symmetry) and the monoclinic (c2/m symmetry) phases in the nanostructured particles.This work has been supported by the Advanced Structural Materials Program- ESTRUMAT (S2009/MAT-1585) and MAT2010-19837-C06-05. Thanks are extended to NanoPort (FEI)- Eindhoven, especially to Eng. L. Fernando Mendoza and to the Ministry of Science and Technology of Serbia (Project #142010).Publicad

Influence of nanoscale defects on the improvement of photocatalytic activity of Ag/ZnO

This study presents the advances in the field of ZnO/Ag catalysts from the synthesis of hierarchical ZnO nanowires (NWs) decorated with Ag nanoparticles, prepared by a facile solvothermal method at 120°C. It evaluates the photocatalytic efficiency from studying the time reaction of Ag/Zn concentration ratio and the presence of cetyltrimethylammonium bromide (CTAB) as an organic dispersant. X-ray diffraction, scanning electron microscopy, and analytical/high-resolution transmission electron microscopy results confirmed the presence of homogeneous cylindrical ZnO nanowires and quasi-spherical Ag crystals. ZnO NWs exhibited hexagonal wurtzite structure and cubic FCC symmetry in Ag nanoparticles (NPS). Two types of nanostructures, including homogeneous cylindrical ZnO NWs in the absence of Ag and simultaneous presence of ZnO NWs and Ag NPs, formed depending on experimental conditions. The photocatalytic activity was evaluated by studying methylene blue (MB) degradation time under UV light excitation. Diffuse reflectance UV–Vis spectrophotometry (UV–Vis DRS) allowed identifying the ZnO absorption band at ~393 nm. Crystal size varied depending on the reaction time and the addition of CTAB. Synthesis time increased bandgap values, getting better photocatalytic performance in samples synthesized in intermediate times (6 h), higher Ag+/Zn2+ molar ratio (0.2/1.0), and CTAB. According to HRTEM observations, the presence of silver nanocrystals with high content of defects (twinning, stacking faults) could play an essential role in the photocatalytic response. In this context, the specific synthesis conditions of Ag/ZnO might be more appropriate for their use in organic dyes degradation in water and the potential use in protective treatments against materials biodeterioration processes.This work has been supported by the Innovation and Education Ministry (ref. MAT2013-47460-C5-5-P and MAT2016-80875-C3-3-R), the Autonomous Region Program of Madrid (ref. S2018/NMT-4411 and S2013/MIT-2862), the Geomateriales 2 program (S2013/MIT_2914), the TOP Heritage (P2018/NMT-4372) of the Community of Madrid, the Innovation and Education Ministry (MAT201347460-C5-5-P) and the Ministry of Education, Science and Technological Development of Serbia (projects No. 172035 and 45020). Besides, we would like to thank the Master of “Materials Science” of Carlos III University (Spain) for providing financial and laboratory equipment support

Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial

Background Previous evidence supports androgen deprivation therapy (ADT) with primary radiotherapy as initial treatment for intermediate-risk and high-risk localised prostate cancer. However, the use and optimal duration of ADT with postoperative radiotherapy after radical prostatectomy remains uncertain. Methods RADICALS-HD was a randomised controlled trial of ADT duration within the RADICALS protocol. Here, we report on the comparison of short-course versus long-course ADT. Key eligibility criteria were indication for radiotherapy after previous radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to add 6 months of ADT (short-course ADT) or 24 months of ADT (long-course ADT) to radiotherapy, using subcutaneous gonadotrophin-releasing hormone analogue (monthly in the short-course ADT group and 3-monthly in the long-course ADT group), daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as metastasis arising from prostate cancer or death from any cause. The comparison had more than 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 75% to 81% (hazard ratio [HR] 0·72). Standard time-to-event analyses were used. Analyses followed intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov , NCT00541047 . Findings Between Jan 30, 2008, and July 7, 2015, 1523 patients (median age 65 years, IQR 60–69) were randomly assigned to receive short-course ADT (n=761) or long-course ADT (n=762) in addition to postoperative radiotherapy at 138 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 8·9 years (7·0–10·0), 313 metastasis-free survival events were reported overall (174 in the short-course ADT group and 139 in the long-course ADT group; HR 0·773 [95% CI 0·612–0·975]; p=0·029). 10-year metastasis-free survival was 71·9% (95% CI 67·6–75·7) in the short-course ADT group and 78·1% (74·2–81·5) in the long-course ADT group. Toxicity of grade 3 or higher was reported for 105 (14%) of 753 participants in the short-course ADT group and 142 (19%) of 757 participants in the long-course ADT group (p=0·025), with no treatment-related deaths. Interpretation Compared with adding 6 months of ADT, adding 24 months of ADT improved metastasis-free survival in people receiving postoperative radiotherapy. For individuals who can accept the additional duration of adverse effects, long-course ADT should be offered with postoperative radiotherapy. Funding Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Background Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. Methods RADICALS-HD was an international randomised controlled trial to test the efficacy of ADT used in combination with postoperative radiotherapy for prostate cancer. Key eligibility criteria were indication for radiotherapy after radical prostatectomy for prostate cancer, prostate-specific antigen less than 5 ng/mL, absence of metastatic disease, and written consent. Participants were randomly assigned (1:1) to radiotherapy alone (no ADT) or radiotherapy with 6 months of ADT (short-course ADT), using monthly subcutaneous gonadotropin-releasing hormone analogue injections, daily oral bicalutamide monotherapy 150 mg, or monthly subcutaneous degarelix. Randomisation was done centrally through minimisation with a random element, stratified by Gleason score, positive margins, radiotherapy timing, planned radiotherapy schedule, and planned type of ADT, in a computerised system. The allocated treatment was not masked. The primary outcome measure was metastasis-free survival, defined as distant metastasis arising from prostate cancer or death from any cause. Standard survival analysis methods were used, accounting for randomisation stratification factors. The trial had 80% power with two-sided α of 5% to detect an absolute increase in 10-year metastasis-free survival from 80% to 86% (hazard ratio [HR] 0·67). Analyses followed the intention-to-treat principle. The trial is registered with the ISRCTN registry, ISRCTN40814031, and ClinicalTrials.gov, NCT00541047. Findings Between Nov 22, 2007, and June 29, 2015, 1480 patients (median age 66 years [IQR 61–69]) were randomly assigned to receive no ADT (n=737) or short-course ADT (n=743) in addition to postoperative radiotherapy at 121 centres in Canada, Denmark, Ireland, and the UK. With a median follow-up of 9·0 years (IQR 7·1–10·1), metastasis-free survival events were reported for 268 participants (142 in the no ADT group and 126 in the short-course ADT group; HR 0·886 [95% CI 0·688–1·140], p=0·35). 10-year metastasis-free survival was 79·2% (95% CI 75·4–82·5) in the no ADT group and 80·4% (76·6–83·6) in the short-course ADT group. Toxicity of grade 3 or higher was reported for 121 (17%) of 737 participants in the no ADT group and 100 (14%) of 743 in the short-course ADT group (p=0·15), with no treatment-related deaths. Interpretation Metastatic disease is uncommon following postoperative bed radiotherapy after radical prostatectomy. Adding 6 months of ADT to this radiotherapy did not improve metastasis-free survival compared with no ADT. These findings do not support the use of short-course ADT with postoperative radiotherapy in this patient population

Nanostructured (Y1-Xgdx)(2)O-3:Eu3+ Powders Obtained Through Aerosol Synthesis

In this study, nanophase, spherical, polycrystalline (Y1-xGdx)(2)O-3:Eu3+ phosphor particles were synthesized from aerosols of corresponding nitrate solutions, ultrasonically generated at 1.3 MHz frequency, and thermally decomposed at 900 and 1100 degrees C. Structural and morphological analyses done by X-ray powder diffraction (XRPD) and transmission electron microscopy analysis (TEM) implied the formation of non-aggregated spherical, submicronic particles with smooth particle surfaces and filled morphology. The phase development and structural changes, determined using the Topas program, implied a nanocrystalline inner structure (crystallites LT 20 nm), that was also confirmed by SAED analysis. A bcc Ia-3 cubic phase was identified in all as-prepared samples, apart from the mixed oxide with the gadolinium content GT 75%, where the existence of a secondary, fcc Fm-3m cubic phase is determined. Only Ia-3 cubic phase was identified in thermally treated samples (1100 degrees C), while the powder morphological features were maintained, followed by increase in powder crystallinity and phase homogeneity. Functional properties were analyzed by means of photoluminescent analysis. Emission spectra showed typical Eu3+ D-5(0) - GT (7)Fi (i = 0, 1, 2, 3, 4) transitions with the dominant red emission peak at 611 nm.Ceramic Transactions, 3rd International Conference on Characterization and Control of Interfaces for High Quality Advanced Materials, 2009, Kurashiki, Japa

Nanostructured (Y1-Xgdx)(2)O-3:Eu3+ Powders Obtained Through Aerosol Synthesis

In this study, nanophase, spherical, polycrystalline (Y1-xGdx)(2)O-3:Eu3+ phosphor particles were synthesized from aerosols of corresponding nitrate solutions, ultrasonically generated at 1.3 MHz frequency, and thermally decomposed at 900 and 1100 degrees C. Structural and morphological analyses done by X-ray powder diffraction (XRPD) and transmission electron microscopy analysis (TEM) implied the formation of non-aggregated spherical, submicronic particles with smooth particle surfaces and filled morphology. The phase development and structural changes, determined using the Topas program, implied a nanocrystalline inner structure (crystallites LT 20 nm), that was also confirmed by SAED analysis. A bcc Ia-3 cubic phase was identified in all as-prepared samples, apart from the mixed oxide with the gadolinium content GT 75%, where the existence of a secondary, fcc Fm-3m cubic phase is determined. Only Ia-3 cubic phase was identified in thermally treated samples (1100 degrees C), while the powder morphological features were maintained, followed by increase in powder crystallinity and phase homogeneity. Functional properties were analyzed by means of photoluminescent analysis. Emission spectra showed typical Eu3+ D-5(0) - GT (7)Fi (i = 0, 1, 2, 3, 4) transitions with the dominant red emission peak at 611 nm.Ceramic Transactions, 3rd International Conference on Characterization and Control of Interfaces for High Quality Advanced Materials, 2009, Kurashiki, Japa